No significant difference was observed in β2-M transcript expression levels between the ER+ and ER− breast cancer groups (P = 0.731) and the HER-2+ and HER-2− breast cancer groups (P = 0.426). The gene discussed is ERBB2; the disease is breast carcinoma.